Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Symonds

Showing results (191-200 of 324) with videos related to

Pageof 33
Sort By:
Human Gene Therapy|March 17, 2004
Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patientsRafael G Amado, Ronald T Mitsuyasu, Joseph D Rosenblatt, et al.
Plos One|January 10, 2013
Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT miceGene-Errol E Ringpis, Saki Shimizu, Hubert Arokium, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitorOrit Wolstein, Maureen Boyd, Michelle Millington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials GroupS B Kaye, J Paul, J Cassidy, et al.
Molecular Therapy. Nucleic Acids|April 15, 2015
Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral VectorBryan P Burke, Bernard R Levin, Jane Zhang, et al.
Nature Medicine|February 17, 2009
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cellsRonald T Mitsuyasu, Thomas C Merigan, Andrew Carr, et al.
Nature Microbiology|May 31, 2022
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in AustraliaAnupriya Aggarwal, Alberto Ospina Stella, Gregory Walker, et al.
Physical Review Letters|May 14, 2016
Measurement of Long-Range Near-Side Two-Particle Angular Correlations in pp Collisions at sqrt[s]=13  TeVV Khachatryan, A M Sirunyan, A Tumasyan, et al.
The European Physical Journal. C, Particles and Fields|July 7, 2015
Constraints on parton distribution functions and extraction of the strong coupling constant from the inclusive jet cross section in pp collisions at [Formula: see text][Formula: see text]V Khachatryan, A M Sirunyan, A Tumasyan, et al.
The European Physical Journal. C, Particles and Fields|January 28, 2020
Search for dark matter produced in association with heavy-flavor quark pairs in proton-proton collisions at <math> </math>A M Sirunyan, A Tumasyan, W Adam, et al.
Pageof 33

Showing results (191-200 of 324) with videos related to

Sort By:
Pageof 33
Human Gene Therapy|March 17, 2004
Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patientsRafael G Amado, Ronald T Mitsuyasu, Joseph D Rosenblatt, et al.
Plos One|January 10, 2013
Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT miceGene-Errol E Ringpis, Saki Shimizu, Hubert Arokium, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitorOrit Wolstein, Maureen Boyd, Michelle Millington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials GroupS B Kaye, J Paul, J Cassidy, et al.
Molecular Therapy. Nucleic Acids|April 15, 2015
Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral VectorBryan P Burke, Bernard R Levin, Jane Zhang, et al.
Nature Medicine|February 17, 2009
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cellsRonald T Mitsuyasu, Thomas C Merigan, Andrew Carr, et al.
Nature Microbiology|May 31, 2022
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in AustraliaAnupriya Aggarwal, Alberto Ospina Stella, Gregory Walker, et al.
Physical Review Letters|May 14, 2016
Measurement of Long-Range Near-Side Two-Particle Angular Correlations in pp Collisions at sqrt[s]=13  TeVV Khachatryan, A M Sirunyan, A Tumasyan, et al.
The European Physical Journal. C, Particles and Fields|July 7, 2015
Constraints on parton distribution functions and extraction of the strong coupling constant from the inclusive jet cross section in pp collisions at [Formula: see text][Formula: see text]V Khachatryan, A M Sirunyan, A Tumasyan, et al.
The European Physical Journal. C, Particles and Fields|January 28, 2020
Search for dark matter produced in association with heavy-flavor quark pairs in proton-proton collisions at <math> </math>A M Sirunyan, A Tumasyan, W Adam, et al.
Pageof 33